Vigorito Elena, Perks Kerry L, Abreu-Goodger Cei, Bunting Sam, Xiang Zou, Kohlhaas Susan, Das Partha P, Miska Eric A, Rodriguez Antony, Bradley Allan, Smith Kenneth G C, Rada Cristina, Enright Anton J, Toellner Kai-Michael, Maclennan Ian C M, Turner Martin
Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, CB22 3AT, UK.
Immunity. 2007 Dec;27(6):847-59. doi: 10.1016/j.immuni.2007.10.009. Epub 2007 Dec 6.
microRNA-155 (miR-155) is expressed by cells of the immune system after activation and has been shown to be required for antibody production after vaccination with attenuated Salmonella. Here we show the intrinsic requirement for miR-155 in B cell responses to thymus-dependent and -independent antigens. B cells lacking miR-155 generated reduced extrafollicular and germinal center responses and failed to produce high-affinity IgG1 antibodies. Gene-expression profiling of activated B cells indicated that miR-155 regulates an array of genes with diverse function, many of which are predicted targets of miR-155. The transcription factor Pu.1 is validated as a direct target of miR155-mediated inhibition. When Pu.1 is overexpressed in wild-type B cells, fewer IgG1 cells are produced, indicating that loss of Pu.1 regulation is a contributing factor to the miR-155-deficient phenotype. Our results implicate post-transcriptional regulation of gene expression for establishing the terminal differentiation program of B cells.
Immunity. 2007-12
Immunology. 2016-6
J Clin Invest. 2018-8-20
J Extracell Vesicles. 2025-1
Biomedicines. 2024-11-21
Methods Mol Biol. 2025
Extracell Vesicles Circ Nucl Acids. 2021-4-8
Middle East J Dig Dis. 2024-7
Clin Exp Med. 2024-9-11
Cell Death Discov. 2024-6-21
Science. 2007-4-27
Science. 2007-4-27
Nat Immunol. 2007-4
Proc Natl Acad Sci U S A. 2007-1-30
J Exp Med. 2006-10-30